Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for May 1st, 2012

« Older Entries

Incorporating Targeted Therapies into Community Oncology

By on Tuesday, May 1st, 2012 | No Comments

Panelists discuss two challenges: how community oncologists integrate their clinical services to deliver optimal care and how can they enroll into clinical trials small groups of patients who might benefit from targeted therapy.

Read More...

Skin Cancer Cure in a Pill?

By on Tuesday, May 1st, 2012 | No Comments

www.insidershealth.com Erivedge –The Pill That May Cure Skin Cancer Can Skin Cancer Be Cured with a Pill? No More Skin Cancer! #ihtv #insidershealth #ihnews There’s a hot new pill soon to hit the health care industry. It’s called Erivedge and its job is to battle and possibly even cure skin cancer! Can a pill really cure skin cancer? The odds are in its favor. Though it can be pricey, the positives far outweigh the negatives for the new treatment. Kudos to the FDA for recognizing its remarkable ability to fight this disease and for pushing it through for quick approval! For more info on skin cancer, please click on the links below! FDA Approves Drug for Skin Cancer: Truly Effective, or Just Another Money-Maker? www.insidershealth.com 5 Nutrients that Stop Skin Cancer www.insidershealth.com Prevent Skin Cancer with these 6 Simple Steps www.insidershealth.com

Read More...

Surgiscreen Registration

By on Tuesday, May 1st, 2012 | No Comments

Condition :   Irregular Antibody Screening Intervention :   Sponsors :   Johnson & Johnson Medical, China;   Johnson & Johnson Medical, China Not yet recruiting – verified April 2012

Read More...

China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids

By on Tuesday, May 1st, 2012 | No Comments

Condition :   Uterine Fibroids Intervention :   Device: MR-HIFU uterine fibroid treatment Sponsors :   Philips Healthcare;   Philips Healthcare Not yet recruiting – verified April 2012

Read More...

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

By on Tuesday, May 1st, 2012 | No Comments

Condition :   Hormone Receptor Positive Malignant Neoplasm of Breast Interventions :   Drug: Metformin;   Drug: Placebo Sponsors :   Seoul National University Hospital;   Seoul National University Hospital Not yet recruiting – verified April 2012

Read More...

Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

By on Tuesday, May 1st, 2012 | No Comments

Conditions :   Squamous Cell Carcinoma of the Skin;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage II Verrucous Carcinoma of the Oral Cavity Interventions :   Drug: erlotinib hydrochloride;   Procedure: therapeutic conventional surgery Sponsors :   Comprehensive Cancer Center of Wake Forest University;   Comprehensive Cancer Center of Wake Forest University;   National Cancer Institute (NCI) Recruiting – verified April 2012

Read More...

Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma

By on Tuesday, May 1st, 2012 | No Comments

Condition :   Multiple Myeloma Intervention :   Drug: Pomalidomide Sponsors :   Celgene Corporation;   Celgene Corporation Available – verified April 2012

Read More...

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

By on Tuesday, May 1st, 2012 | No Comments

Conditions :   Prolymphocytic Leukemia;   Recurrent Small Lymphocytic Lymphoma;   Refractory/Relapsed Chronic Lymphocytic Leukemia Interventions :   Drug: ibrutinib;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: pharmacological study Sponsors :   Ohio State University Comprehensive Cancer Center;   Kami Maddocks-Christianson Not yet recruiting – verified April 2012

Read More...

Safety Study of Topical Compound 31543 (Calcitriol, USP) in Patients Receiving Chemotherapy for Breast Cancer

By on Tuesday, May 1st, 2012 | No Comments

Conditions :   Alopecia;   Breast Cancer Intervention :   Drug: compound 31543 Calcitriol Sponsors :   Berg Pharma,LLC;   Berg Pharma,LLC Not yet recruiting – verified April 2012

Read More...

Personalized Consolidation Therapy Based on Leukemia Stem Cell Behavior

By on Tuesday, May 1st, 2012 | No Comments

Condition :   Acute Myeloid Leukemia Interventions :   Drug: Cytarabine consolidation;   Drug: Cytarabine vs BMT Sponsors :   Sidney Kimmel Comprehensive Cancer Center;   Sidney Kimmel Comprehensive Cancer Center Not yet recruiting – verified April 2012

Read More...
« Older Entries